Lubiprostone + Lubiprostone + Lubiprostone
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Constipation
Conditions
Constipation
Trial Timeline
Jan 1, 2007 → Oct 1, 2008
NCT ID
NCT00452335About Lubiprostone + Lubiprostone + Lubiprostone
Lubiprostone + Lubiprostone + Lubiprostone is a approved stage product being developed by Mallinckrodt Pharmaceuticals for Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT00452335. Target conditions include Constipation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00452335 | Approved | Completed |
Competing Products
20 competing products in Constipation